Demonstrates a biomarker-driven approach to refine diagnosis in local allergic rhinitis, indicating better patient selection for therapies.
A local sIgE threshold reliably identifies an immunologically distinct LAR endotype, aligning diagnosis with its type 2 pathophysiology. This biomarker-driven approach offers a precise tool to refine diagnostic algorithms and improve patient selection for targeted therapies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: